Surgical Science Sweden AB (publ) (SUSRF)
OTCMKTS · Delayed Price · Currency is USD
14.39
0.00 (0.00%)
At close: Aug 6, 2025
Alteryx Market Cap
SUSRF has a market cap or net worth of $731.58 million as of August 6, 2025. Its market cap has increased by 19.69% in one year.
Market Cap
731.58M
Enterprise Value
668.07M
Revenue
94.30M
Ranking
n/a
PE Ratio
52.05
Stock Price
$14.39
Market Cap Chart
Since June 19, 2017, SUSRF's market cap has increased from 32.05M to 731.58M, an increase of 2,182.84%. That is a compound annual growth rate of 46.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 731.58M | 1.57% |
| Dec 30, 2024 | 720.24M | -22.00% |
| Dec 29, 2023 | 923.33M | 15.03% |
| Dec 30, 2022 | 802.66M | -49.23% |
| Dec 30, 2021 | 1.58B | 301.67% |
| Dec 30, 2020 | 393.59M | 28.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |